3D LifePrints, UK firm has revealed a successful venture round. The £1.2 million in finance is directed by Fenwall Investments and will move to accelerate the award-winning pharmaceutical additive manufacturing businesses’ appearance in the regional and global business.
This newest round comes after grants made in 2018 and 2017. The company is built upon a design that leverages 3D printing for healthcare solutions. 3D printed medical machines, fixed bio-medical engineers and assistance to the universities, NHS, private healthcare amenities and research organizations are among the services and products accessible.
Medical machines made consist of anatomical models, titanium implants for Cranio-maxillofacial surgery, and surgical guides.
3D LifePrints offers these services from fixed additive manufacturing hubs or facilities at hospitals. Presently, medical additive manufacturing centers are at Alder Hey Children’s Hospital in Liverpool, Nuffield Orthopaedic Centre in Oxford and Wrightington Hospital in Manchester. Through the establishment of a hub, the firm has the ability to lessen operational expenses and enhance patient care.
With the freshly released funding, the company intends to bring the center model to more towns in the United Kingdom. This is specifically London, Manchester, Leeds, and Birmingham. Also, extension in mainland Europe and the USA is on the skyline.
“We are extremely pleased to announce the completion of this funding round with investment from Fenwall Investments and a number of individual investors, and will continue to develop our unique business model of providing embedded 3D medical printing services in order to drive down operational costs, provide innovative 3D technology-based products and services, and ultimately improve patient care,” says Founder and CTO for 3D LifePrints, Paul Fotheringham.
“I’m delighted that Fenwall are re-investing in us. They are a perfect long-term partner for 3D LifePrints, with a shared set of values and a vision for improving healthcare across the globe,” said Co-Founder, and CEO for 3D LifePrints, Henry Pinchbeck.
Also, the Managing Director of Fenwall Investments Ltd, Dr. Andrew Douglas, said that they are happy to part of the talented crew working in a growing and fast-developing business. He said they believe the timing is excellent to enable 3D LifePrints to benefit from its potential. “I’m looking forward to an exciting and profitable partnership,” he added.
